1azy Citations

Structural and theoretical studies suggest domain movement produces an active conformation of thymidine phosphorylase.

J Mol Biol 281 285-99 (1998)
Related entries: 1otp, 2tpt

Cited: 37 times
EuropePMC logo PMID: 9698549

Abstract

Two new crystal forms of Escherichia coli thymidine phosphorylase (EC 2.4.2.4) have been found; a monoclinic form (space group P21) and an orthorhombic form (space group I222). These structures have been solved and compared to the previously determined tetragonal form (space group P43212). This comparison provides evidence of domain movement of the alpha (residues 1 to 65, 163 to 193) and alpha/beta (residues 80 to 154, 197 to 440) domains, which is thought to be critical for enzymatic activity by closing the active site cleft. Three hinge regions apparently allow the alpha and alpha/beta-domains to move relative to each other. The monoclinic model is the most open of the three models while the tetragonal model is the most closed. Phosphate binding induces formation of a hydrogen bond between His119 and Gly208, which helps to order the 115 to 120 loop that is disordered prior to phosphate binding. The formation of this hydrogen bond also appears to play a key role in the domain movement. The alpha-domain moves as a rigid body, while the alpha/beta-domain has some non-rigid body movement that is associated with the formation of the His119-Gly208 hydrogen bond. The 8 A distance between the two substrates reported for the tetragonal form indicates that it is probably not in an active conformation. However, the structural data for these two new crystal forms suggest that closing the interdomain cleft around the substrates may generate a functional active site. Molecular modeling and dynamics simulation techniques have been used to generate a hypothetical closed conformation of the enzyme. Analysis of this model suggests several residues of possible catalytic importance. The model explains observed kinetic results and satisfies requirements for efficient enzyme catalysis, most notably through the exclusion of water from the enzyme's active site.

Articles - 1azy mentioned but not cited (1)

  1. Comparing interfacial dynamics in protein-protein complexes: an elastic network approach. Zen A, Micheletti C, Keskin O, Nussinov R. BMC Struct Biol 10 26 (2010)


Reviews citing this publication (5)

  1. Structural analyses reveal two distinct families of nucleoside phosphorylases. Pugmire MJ, Ealick SE. Biochem J 361 1-25 (2002)
  2. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Bronckaers A, Gago F, Balzarini J, Liekens S. Med Res Rev 29 903-953 (2009)
  3. Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Li W, Yue H. Trends Cardiovasc Med 28 157-171 (2018)
  4. A kinetic, modeling and mechanistic re-analysis of thymidine phosphorylase and some related enzymes. Edwards PN. J Enzyme Inhib Med Chem 21 483-499 (2006)
  5. Protein Dynamics and Enzymatic Catalysis. Schwartz SD. J Phys Chem B 127 2649-2660 (2023)

Articles citing this publication (31)

  1. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Nishino I, Spinazzola A, Hirano M. Science 283 689-692 (1999)
  2. Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor. Norman RA, Barry ST, Bate M, Breed J, Colls JG, Ernill RJ, Luke RW, Minshull CA, McAlister MS, McCall EJ, McMiken HH, Paterson DS, Timms D, Tucker JA, Pauptit RA. Structure 12 75-84 (2004)
  3. The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation. Pugmire MJ, Ealick SE. Structure 6 1467-1479 (1998)
  4. Three-dimensional structure of a hyperthermophilic 5'-deoxy-5'-methylthioadenosine phosphorylase from Sulfolobus solfataricus. Appleby TC, Mathews II, Porcelli M, Cacciapuoti G, Ealick SE. J Biol Chem 276 39232-39242 (2001)
  5. Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. Li W, Gigante A, Perez-Perez MJ, Yue H, Hirano M, McIntyre TM, Silverstein RL. Circ Res 115 997-1006 (2014)
  6. Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium. Caradoc-Davies TT, Cutfield SM, Lamont IL, Cutfield JF. J Mol Biol 337 337-354 (2004)
  7. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase. Balzarini J, Degrève B, Esteban-Gamboa A, Esnouf R, De Clercq E, Engelborghs Y, Camarasa MJ, Pérez-Pérez MJ. FEBS Lett 483 181-185 (2000)
  8. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. Shahzad SA, Yar M, Bajda M, Jadoon B, Khan ZA, Naqvi SA, Shaikh AJ, Hayat K, Mahmmod A, Mahmood N, Filipek S. Bioorg Med Chem 22 1008-1015 (2014)
  9. The crystal structure of anthranilate phosphoribosyltransferase from the enterobacterium Pectobacterium carotovorum. Kim C, Xuong NH, Edwards S, Madhusudan, Yee MC, Spraggon G, Mills SE. FEBS Lett 523 239-246 (2002)
  10. Structural analysis of two enzymes catalysing reverse metabolic reactions implies common ancestry. Mayans O, Ivens A, Nissen LJ, Kirschner K, Wilmanns M. EMBO J 21 3245-3254 (2002)
  11. Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase. Schwartz PA, Vetticatt MJ, Schramm VL. J Am Chem Soc 132 13425-13433 (2010)
  12. Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design. El Omari K, Bronckaers A, Liekens S, Pérez-Pérez MJ, Balzarini J, Stammers DK. Biochem J 399 199-204 (2006)
  13. Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase. Schwartz PA, Vetticatt MJ, Schramm VL. Biochemistry 50 1412-1420 (2011)
  14. A rationally designed monomeric variant of anthranilate phosphoribosyltransferase from Sulfolobus solfataricus is as active as the dimeric wild-type enzyme but less thermostable. Schwab T, Skegro D, Mayans O, Sterner R. J Mol Biol 376 506-516 (2008)
  15. Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening. McNally VA, Gbaj A, Douglas KT, Stratford IJ, Jaffar M, Freeman S, Bryce RA. Bioorg Med Chem Lett 13 3705-3709 (2003)
  16. Indispensable residue for uridine binding in the uridine-cytidine kinase family. Tomoike F, Nakagawa N, Fukui K, Yano T, Kuramitsu S, Masui R. Biochem Biophys Rep 11 93-98 (2017)
  17. Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59). Bronckaers A, Aguado L, Negri A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ, Gago F, Liekens S. Biochem Pharmacol 78 231-240 (2009)
  18. Computational studies of the domain movement and the catalytic mechanism of thymidine phosphorylase. Rick SW, Abashkin YG, Hilderbrandt RL, Burt SK. Proteins 37 242-252 (1999)
  19. Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants. Gbaj A, Edwards PN, Reigan P, Freeman S, Jaffar M, Douglas KT. J Enzyme Inhib Med Chem 21 69-73 (2006)
  20. Substrate specificity of Escherichia coli thymidine phosphorylase. Panova NG, Alexeev CS, Kuzmichov AS, Shcheveleva EV, Gavryushov SA, Polyakov KM, Kritzyn AM, Mikhailov SN, Esipov RS, Miroshnikov AI. Biochemistry (Mosc) 72 21-28 (2007)
  21. 3'-Azidothymidine in the active site of Escherichia coli thymidine phosphorylase: the peculiarity of the binding on the basis of X-ray study. Timofeev V, Abramchik Y, Zhukhlistova N, Muravieva T, Fateev I, Esipov R, Kuranova I. Acta Crystallogr D Biol Crystallogr 70 1155-1165 (2014)
  22. Structure analysis of archaeal AMP phosphorylase reveals two unique modes of dimerization. Nishitani Y, Aono R, Nakamura A, Sato T, Atomi H, Imanaka T, Miki K. J Mol Biol 425 2709-2721 (2013)
  23. An investigation of the kinetic and anti-angiogenic properties of plant glycoside inhibitors of thymidine phosphorylase. Hussain S, Gaffney J, Ahmed N, Slevin M, Iqbal Choudhary M, Ahmad VU, Qasmi Z, Abbasi MA. J Asian Nat Prod Res 11 159-167 (2009)
  24. One-pot approach to functional nucleosides possessing a fluorescent group using nucleobase-exchange reaction by thymidine phosphorylase. Hatano A, Kurosu M, Yonaha S, Okada M, Uehara S. Org Biomol Chem 11 6900-6905 (2013)
  25. Role of each residue in catalysis in the active site of pyrimidine nucleoside phosphorylase from Bacillus subtilis: a hybrid QM/MM study. Gao XF, Huang XR, Sun CC. J Struct Biol 154 20-26 (2006)
  26. YbiB from Escherichia coli, the Defining Member of the Novel TrpD2 Family of Prokaryotic DNA-binding Proteins. Schneider D, Kaiser W, Stutz C, Holinski A, Mayans O, Babinger P. J Biol Chem 290 19527-19539 (2015)
  27. Kinetics and mechanistic study of competitive inhibition of thymidine phosphorylase by 5-fluoruracil derivatives. Petaccia M, Gentili P, Bešker N, D'Abramo M, Giansanti L, Leonelli F, La Bella A, Gradella Villalva D, Mancini G. Colloids Surf B Biointerfaces 140 121-127 (2016)
  28. Substrate specificity of thymidine phosphorylase of E. coli: role of hydroxyl groups. Panova NG, Alexeev CS, Polyakov KM, Gavryushov SA, Kritzyn AM, Mikhailov SN. Nucleosides Nucleotides Nucleic Acids 27 1211-1214 (2008)
  29. Crystal structure of pyrimidine-nucleoside phosphorylase from Bacillus subtilis in complex with imidazole and sulfate. Balaev VV, Prokofev II, Gabdoulkhakov AG, Betzel C, Lashkov AA. Acta Crystallogr F Struct Biol Commun 74 193-197 (2018)
  30. Enzymatic synthesis and phosphorolysis of 4(2)-thioxo- and 6(5)-azapyrimidine nucleosides by E. coli nucleoside phosphorylases. Stepchenko VA, Miroshnikov AI, Seela F, Mikhailopulo IA. Beilstein J Org Chem 12 2588-2601 (2016)
  31. Structural investigation of the thymidine phosphorylase from Salmonella typhimurium in the unliganded state and its complexes with thymidine and uridine. Balaev VV, Lashkov AA, Gabdulkhakov AG, Dontsova MV, Seregina TA, Mironov AS, Betzel C, Mikhailov AM. Acta Crystallogr F Struct Biol Commun 72 224-233 (2016)


Related citations provided by authors (1)

  1. Three-Dimensional Structure of Thymidine Phosphorylase from Escherichia Coli at 2.8 A Resolution. Walter MR, Cook WJ, Cole LB, Short SA, Koszalka GW, Krenitsky TA, Ealick SE J. Biol. Chem. 265 14016- (1990)